First Wave BioPharma Financials

FWBIDelisted Stock  USD 0.61  0.03  4.69%   
Based on the measurements of operating efficiency obtained from First Wave's historical financial statements, First Wave BioPharma is not in a good financial situation at the moment. It has a very high risk of going through financial straits in January.
  
Understanding current and past First Wave Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of First Wave's financial statements are interrelated, with each one affecting the others. For example, an increase in First Wave's assets may result in an increase in income on the income statement.

First Wave Stock Summary

First Wave competes with Quoin Pharmaceuticals, Revelation Biosciences, Dermata Therapeutics, LMF Acquisition, and ZyVersa Therapeutics. First Wave BioPharma, Inc., a clinical-stage biopharmaceutical company, engages in the research and development of targeted and non-systemic therapies for the treatment of patients with gastrointestinal diseases. First Wave BioPharma, Inc. was incorporated in 2014 and is headquartered in Boca Raton, Florida. First Wave operates under Biotechnology classification in the United States and is traded on NASDAQ Exchange. It employs 17 people.
InstrumentUSA Stock View All
ExchangeNASDAQ Exchange
ISINUS33749P1012
Business Address777 Yamato Road,
New SymbolENTO
SectorBiotechnology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.firstwavebio.com
Phone561 589 7020
CurrencyUSD - US Dollar

First Wave Key Financial Ratios

First Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining First Wave's current stock value. Our valuation model uses many indicators to compare First Wave value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across First Wave competition to find correlations between indicators driving First Wave's intrinsic value. More Info.
First Wave BioPharma is rated # 2 in return on equity category among its peers. It is rated # 4 in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the First Wave's earnings, one of the primary drivers of an investment's value.

First Wave Market Pulse

 Quote0.61
 Change(%)  4.69 
 Change0.03 
 Open0.64
 Low0.59
 High0.66
 Volume0
 ExchangeNASDAQ

About First Wave Financials

What exactly are First Wave Financials? Typically, a company's financial statements are the reports that show the financial position of the company. Three primary documents fall into the category of financial statements. These documents include First Wave's income statement, its balance sheet, and the statement of cash flows. Potential First Wave investors and stakeholders use financial statements to determine how well the company is positioned to perform in the future. Although First Wave investors may use each financial statement separately, they are all related. The changes in First Wave's assets and liabilities, for example, are also reflected in the revenues and expenses that we see on First Wave's income statement, which results in the company's gains or losses. Cash flows can provide more information regarding cash listed on a balance sheet, but not equivalent to net income shown on the income statement. Please read more on our technical analysis and fundamental analysis pages.

First Wave December 1, 2024 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of First Wave help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of First Wave BioPharma. We use our internally-developed statistical techniques to arrive at the intrinsic value of First Wave BioPharma based on widely used predictive technical indicators. In general, we focus on analyzing First Stock price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build First Wave's daily price indicators and compare them against related drivers.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in bureau of labor statistics.
You can also try the Equity Forecasting module to use basic forecasting models to generate price predictions and determine price momentum.

Other Consideration for investing in First Stock

If you are still planning to invest in First Wave BioPharma check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the First Wave's history and understand the potential risks before investing.
Equity Analysis
Research over 250,000 global equities including funds, stocks and ETFs to find investment opportunities
ETF Categories
List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments
Equity Valuation
Check real value of public entities based on technical and fundamental data
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Funds Screener
Find actively-traded funds from around the world traded on over 30 global exchanges
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Investing Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Fundamentals Comparison
Compare fundamentals across multiple equities to find investing opportunities
Aroon Oscillator
Analyze current equity momentum using Aroon Oscillator and other momentum ratios